pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

7,525 catalysts · 3,350 8k filing · 1,096 grant · 1,000 device adverse event · 580 earnings · 550 approval · 430 device 510k

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-10: 0 catalysts2026-08-11: 0 catalysts2026-08-12: 0 catalysts2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 1 catalyst2026-08-18: 2 catalysts2026-08-19: 3 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
from 2026-03-02×clear all
type
  • 8k filing3,350
  • grant1,096
  • device adverse event1,000
  • earnings580
  • approval550
  • device 510k430
  • device pma248
  • phase 2 completion172
  • drug shortage133
  • recall121
  • therapy area
    • Oncology148
    • Infectious Disease46
    • Cardiology37
    • Immunology35
    • Dermatology31
    • Pulmonology22
    • Women's Health19
    • Ophthalmology16
    • Pain15

    Week of Mar 16, 2026

    10
    ›Mar 20, 2026grant150d agoUNIVERSITY OF PENNSYLVANIA — Therapeutic editing for cardiovascular diseasesUniversity of Pennsylvania

    HL grant. $1,137,435. PI: Kiran Musunuru

    full page →nih reporter ↗
    ›Mar 20, 2026grant150d agoWEILL MEDICAL COLL OF CORNELL UNIV — AYA Cohort to Enhance Survivorship in NYC (ACES-NYC)

    CA grant. $1,053,426. PI: Danielle Friedman

    full page →nih reporter ↗
    ›Mar 20, 2026grant150d agoYALE UNIVERSITY — Impact of peripheral inflammation on microglia and neurons in aging

    AG grant. $746,160. PI: Emilia Favuzzi

    full page →nih reporter ↗
    ›Mar 20, 2026grant150d agoEMORY UNIVERSITY — Mechanisms of angiotensin II signaling within intercalated cellsEmory University

    DK grant. $821,916. PI: SUSAN MARIE WALL

    full page →nih reporter ↗
    ›Mar 20, 2026grant150d agoUNIVERSITY OF PENNSYLVANIA — Comparative Effectiveness Trial of Low Barrier Access to Preferred Firearm Se...University of Pennsylvania

    NR grant. $732,795. PI: Mucio Delgado

    full page →nih reporter ↗
    ›Mar 20, 2026grant150d agoBRIGHAM AND WOMEN'S HOSPITAL — Technology development center for integrative physiologic models of the human...Brigham and Women's Hospital

    TR grant. $3,516,688. PI: April Marie Craft

    full page →nih reporter ↗
    ›Mar 20, 2026grant150d agoMAYO CLINIC ROCHESTER — Blood-based tumor and immune markers for risk stratification and monitoring t...Mayo Clinic

    CA grant. $667,710. PI: Aadel Chaudhuri

    full page →nih reporter ↗
    ›Mar 21, 2026grant149d agoUNIVERSITY OF WASHINGTON — Estrogen across the menstrual cycle for females with inflammatory bowel diseaseUniversity of Washington

    DK grant. $782,361. PI: Kendra Joy Kamp

    full page →nih reporter ↗
    ›Mar 21, 2026grant149d agoRUTGERS BIOMEDICAL AND HEALTH SCIENCES — Clinical Trial Support for the Rutgers Cancer Institute and the RWJBarnabas H...

    CA grant. $975,000. PI: Missak Haigentz

    full page →nih reporter ↗
    ›Mar 22, 2026grant148d agoUT SOUTHWESTERN MEDICAL CENTER — Dissecting the Network Physiology of Pallidal Burst Stimulation

    NS grant. $487,858. PI: Luka Milosevic

    full page →nih reporter ↗

    Week of Mar 23, 2026

    40
    ›Mar 23, 2026approval147d agoKETALAR (KETAMINE HYDROCHLORIDE) — FDA approvalPar Pharmaceutical Inc

    Sponsor: PH HEALTH. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Mar 23, 2026approval
    ← prev
    page 21 of 151
    next →
    147d ago
    CLINDAMYCIN PHOSPHATE — FDA approvalCLEOCIN

    Sponsor: RISING. Form: SOLUTION. Route: TOPICAL

    full page →CLEOCIN →fda approvals ↗
    ›Mar 23, 2026approval147d agoCEFIXIME — FDA approvalCEFIXIME

    Sponsor: AUROBINDO PHARMA LTD. Form: CAPSULE. Route: ORAL

    full page →CEFIXIME →fda approvals ↗
    ›Mar 23, 2026approval147d agoCINACALCET HYDROCHLORIDE — FDA approvalCINACALCET HYDROCHLORIDE

    Sponsor: AUROBINDO PHARMA LTD. Form: TABLET. Route: ORAL

    full page →CINACALCET HYDROCHLORIDE →fda approvals ↗
    ›Mar 23, 2026approval147d agoTRAMADOL HYDROCHLORIDE — FDA approvaltramadol hydrochloride ER

    Sponsor: STRIDES PHARMA. Form: TABLET. Route: ORAL

    full page →tramadol hydrochloride ER →fda approvals ↗
    ›Mar 23, 2026approval147d agoMEXILETINE HYDROCHLORIDE — FDA approvalMEXILETINE HYDROCHLORIDE

    Sponsor: MACLEODS PHARMS LTD. Form: CAPSULE. Route: ORAL

    full page →MEXILETINE HYDROCHLORIDE →fda approvals ↗
    ›Mar 23, 2026approval147d agoMALARONE PEDIATRIC (ATOVAQUONE) — FDA approvalatovaquone

    Sponsor: GLAXOSMITHKLINE. Form: TABLET. Route: ORAL

    full page →atovaquone →fda approvals ↗
    ›Mar 23, 2026device 510k147d agoStreck — MDx-Chex for BCN (510k cleared)

    Product code: PMN. Advisory committee: Microbiology. Type: Traditional

    full page →fda device 510k ↗
    ›Mar 23, 2026device 510k147d agoStabiliz Orthopaedics, Inc. — QuikFix External Fixator: Knee-Spanning Pack (510k cleared)

    Product code: KTT. Advisory committee: Orthopedic. Type: Traditional

    full page →fda device 510k ↗
    ›Mar 23, 2026device 510k147d agoGe Healthcare Japan Corporation — True Definition DL (510k cleared)

    Product code: JAK. Advisory committee: Radiology. Type: Traditional

    full page →fda device 510k ↗
    ›Mar 23, 2026device 510k147d agoPhilips Healthcare (Suzhou) Co., Ltd. — CT Rembra RT; CT Areta RT; CT Rembra (510k cleared)

    Product code: JAK. Advisory committee: Radiology. Type: Traditional

    full page →fda device 510k ↗
    ›Mar 23, 2026device 510k147d agoAdin Dental Implant Systems , Ltd. — Adin Long Dental Implant System (510k cleared)

    Product code: DZE. Advisory committee: Dental. Type: Traditional

    full page →fda device 510k ↗
    ›Mar 23, 2026device 510k147d agoGuangdong Newdermo Biotech Co., Ltd. — LED Light Therapy Masks (LumiLips FAC07NA) (510k cleared)

    Product code: OHS. Advisory committee: General, Plastic Surgery. Type: Traditional

    full page →fda device 510k ↗
    ›Mar 23, 2026device 510k147d agoThreadstone, LLC — HyperSuture All Green Extension Line (510k cleared)

    Product code: GAT. Advisory committee: General, Plastic Surgery. Type: Traditional

    full page →fda device 510k ↗
    ›Mar 23, 2026device 510k147d agoSkeletal Dynamics, Inc. — Clavicle Fixation System (510k cleared)

    Product code: HRS. Advisory committee: Orthopedic. Type: Abbreviated

    full page →fda device 510k ↗
    ›Mar 23, 2026device pma147d agoInsightec — EXABLATE (PMA supplement)

    Supplement type: Normal 180 Day Track No User Fee. Product code: POH. Advisory committee: NE. Decision: APPR

    full page →fda device pma ↗
    ›Mar 23, 2026device pma147d agoHighridge Medical, LLC — Mobi-C® P&F Cervical Disc Prosthesis (PMA supplement)

    Supplement type: 30-Day Notice. Product code: MJO. Advisory committee: OR. Decision: OK30

    full page →fda device pma ↗
    ›Mar 23, 2026device pma147d agoMedtronic Vascular, Inc. — EverFlex™ Self-Expanding Peripheral Stent System; EverFlex™ Self-Expanding Peripheral Stent with Entrust™ Delivery Syste (PMA supplement)

    Supplement type: 30-Day Notice. Product code: NIP. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Mar 23, 2026device pma147d agoMedtronic Vascular, Inc. — Abre™ Venous Self-expanding Stent System (PMA supplement)

    Supplement type: 30-Day Notice. Product code: QAN. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Mar 23, 2026device pma147d agoABBOTT MEDICAL — Volt PFA Catheter Sensor Enabled™ (PMA supplement)

    Supplement type: Normal 180 Day Track. Product code: QZI. Advisory committee: CV. Decision: APPR

    full page →fda device pma ↗
    ›Mar 23, 2026device pma147d agoHighridge Medical, LLC — Mobi-C® Cervical Disc Prosthesis (PMA supplement)

    Supplement type: 30-Day Notice. Product code: MJO. Advisory committee: OR. Decision: OK30

    full page →fda device pma ↗
    ›Mar 23, 2026device pma147d agoMedtronic Vascular, Inc. — Protégé™ GPS™ Self-Expanding Peripheral Stent System; Protégé™ RX Carotid Stent System (PMA supplement)

    Supplement type: 30-Day Notice. Product code: NIM. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Mar 23, 2026grant147d agoSTANFORD UNIVERSITY — Center for Definitive and Curative Medicine Annual SymposiumStanford University

    TR grant. $30,000. PI: Matthew H Porteus

    full page →nih reporter ↗
    ›Mar 23, 2026grant147d agoUNIVERSITY OF TEXAS AT AUSTIN — Music-4-MS to Improve Cognition in People Living with Multiple Sclerosis: A F...

    NR grant. $430,884. PI: Carolyn Phillips

    full page →nih reporter ↗
    ›Mar 23, 2026grant147d agoAUBURN UNIVERSITY AT AUBURN — Generalizable quantitative analysis of cell spheroid models and tissues using...

    GM grant. $417,061. PI: Christopher J Easley

    full page →nih reporter ↗
    ›Mar 23, 2026grant147d agoUNIVERSITY OF FLORIDA — Navigating the Uncertainties of Thyroid Cancer Risk in GLP-1RA UsersUniversity of Florida

    CA grant. $694,122. PI: Naykky Singh Ospina

    full page →nih reporter ↗
    ›Mar 23, 2026grant147d agoCOLD SPRING HARBOR LABORATORY — CSHL 2026 Conference on the PARP Family & ADP-Ribosylation

    CA grant. $8,000. PI: DAVID J. STEWART

    full page →nih reporter ↗
    ›Mar 24, 2026approval146d agoBISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE (BISOPROLOL FUMARATE) — FDA approvalAurobindo Pharma Ltd

    Sponsor: UNIQUE PHARM. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Mar 24, 2026approval146d agoGUANFACINE HYDROCHLORIDE — FDA approvalGUANFACINE HYDROCHLORIDE

    Sponsor: ASCENT PHARMS INC. Form: TABLET. Route: ORAL

    full page →GUANFACINE HYDROCHLORIDE →fda approvals ↗
    ›Mar 24, 2026approval146d agoTICAGRELOR — FDA approvalTICAGRELOR

    Sponsor: ZHEJIANG JINGXIN. Form: TABLET. Route: ORAL

    full page →TICAGRELOR →fda approvals ↗
    ›Mar 24, 2026approval146d agoAVLAYAH (TIVIDENOFUSP ALFA-EKNM) — FDA approvaltividenofusp alfa

    Sponsor: DENALI THERAPEUTICS INC.. Form: INJECTION. Route: POWDER,FOR SOLUTION

    full page →tividenofusp alfa →fda approvals ↗
    ›Mar 24, 2026approval146d agoCHILDREN'S ZYRTEC ALLERGY (CETIRIZINE HYDROCHLORIDE) — FDA approvalKenvue Inc.

    Sponsor: KENVUE BRANDS. Form: TABLET, CHEWABLE. Route: ORAL

    full page →fda approvals ↗
    ›Mar 24, 2026approval146d agoDYNACIN (MINOCYCLINE HYDROCHLORIDE) — FDA approvalMINOCYCLINE HYDROCHLORIDE

    Sponsor: ALVOGEN. Form: CAPSULE. Route: ORAL

    full page →MINOCYCLINE HYDROCHLORIDE →fda approvals ↗
    ›Mar 24, 2026approval146d agoDYNACIN (MINOCYCLINE HYDROCHLORIDE) — FDA approvalMINOCYCLINE HYDROCHLORIDE

    Sponsor: ALVOGEN. Form: CAPSULE. Route: ORAL

    full page →MINOCYCLINE HYDROCHLORIDE →fda approvals ↗
    ›Mar 24, 2026approval146d agoDYNACIN (MINOCYCLINE HYDROCHLORIDE) — FDA approvalMINOCYCLINE HYDROCHLORIDE

    Sponsor: ALVOGEN. Form: CAPSULE. Route: ORAL

    full page →MINOCYCLINE HYDROCHLORIDE →fda approvals ↗
    ›Mar 24, 2026approval146d agoXARELTO (RIVAROXABAN) — FDA approvalJanssen Therapeutics

    Sponsor: JANSSEN PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Mar 24, 2026approval146d agoXARELTO (RIVAROXABAN) — FDA approvalJanssen Therapeutics

    Sponsor: JANSSEN PHARMS. Form: FOR SUSPENSION. Route: ORAL

    full page →fda approvals ↗
    ›Mar 24, 2026approval146d agoRINGER'S IN PLASTIC CONTAINER (CALCIUM CHLORIDE) — FDA approvalAmneal Pharmaceuticals, Inc.

    Sponsor: OTSUKA ICU MEDCL. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Mar 24, 2026device 510k146d agoGE Medical Systems SCS — Senographe Pristina; SenoBright HD; Pristina Serena; Pristina Serena Bright (510k cleared)

    Product code: MUE. Advisory committee: Radiology. Type: Traditional

    full page →fda device 510k ↗
    ›Mar 24, 2026device 510k146d agoAngiodynamics — NanoKnife Generator (H78720300351US0) (510k cleared)ANGIODYNAMICS INC

    Product code: OAB. Advisory committee: General, Plastic Surgery. Type: Traditional

    full page →fda device 510k ↗
    $ANGO13.82-2.81%
    $AMRX18.15+5.10%
    $DNLI24.40-1.69%
    $KVUE19.200.00%